1 – 5 of 40
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Entrustable professional activities (EPAs) for undergraduate medical education – development and exploration of social validity
(
- Contribution to journal › Article
- 2022
-
Mark
Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors : Follow-up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study
(
- Contribution to journal › Article
- 2021
-
Mark
Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population-based Swedish chronic myeloid leukaemia registry
(
- Contribution to journal › Article
-
Mark
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population
(
- Contribution to journal › Article
- 2018
-
Mark
Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation
(
- Contribution to journal › Article